Cargando…

Agreement between dried blood spots and HemoCue in Tamil Nadu, India

India retains the world’s largest burden of anemia despite decades of economic growth and anemia prevention programming. Accurate screening and estimates of anemia prevalence are critical for successful anemia control. Evidence is mixed on the performance of HemoCue, a point-of-care testing device m...

Descripción completa

Detalles Bibliográficos
Autores principales: Roshania, Reshma P., Mehta, Rukshan V., Shete, Ashwini, Bingewar, Rohini, Kulkarni, Sangeeta, Mahajan, Aprajit, Miller, Grant, Tarozzi, Alessandro, Martorell, Reynaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085154/
https://www.ncbi.nlm.nih.gov/pubmed/33927229
http://dx.doi.org/10.1038/s41598-021-88425-y
_version_ 1783686277350031360
author Roshania, Reshma P.
Mehta, Rukshan V.
Shete, Ashwini
Bingewar, Rohini
Kulkarni, Sangeeta
Mahajan, Aprajit
Miller, Grant
Tarozzi, Alessandro
Martorell, Reynaldo
author_facet Roshania, Reshma P.
Mehta, Rukshan V.
Shete, Ashwini
Bingewar, Rohini
Kulkarni, Sangeeta
Mahajan, Aprajit
Miller, Grant
Tarozzi, Alessandro
Martorell, Reynaldo
author_sort Roshania, Reshma P.
collection PubMed
description India retains the world’s largest burden of anemia despite decades of economic growth and anemia prevention programming. Accurate screening and estimates of anemia prevalence are critical for successful anemia control. Evidence is mixed on the performance of HemoCue, a point-of-care testing device most widely used for large-scale surveys. The use of dried blood spots (DBS) to assess hemoglobin (Hb) concentration is a potential alternative, particularly in field settings. The objective of this study is to assess Hb measurement agreement between capillary HemoCue and DBS among two age groups, children 6–59 months and females age 12–40 years. We analyzed data from the baseline round of a cluster randomized rice fortification intervention in Cuddalore district of Tamil Nadu, India. Capillary blood was collected from a subset of participants for Hb assessment by HemoCue 301 and DBS methods. We calculated Lin’s concordance correlation coefficient, and tested bias by conducting paired t-tests of Hb concentration. Independence of the bias and Hb magnitude was examined visually using Bland–Altman plots and statistically tested by Pearson’s correlation. We assessed differences in anemia classification using McNemar’s test of marginal homogeneity. Concordance between HemoCue and DBS Hb measures was moderate for both children 6–59 months (ρ(c) = 0.67; 95% CI 0.65, 0.71) and females 12–40 years (ρ(c) = 0.67: 95% CI 0.64, 0.69). HemoCue measures were on average 0.06 g/dL higher than DBS for children (95% CI 0.002, 0.12; p = 0.043) and 0.29 g/dL lower than DBS for females (95% CI − 0.34, − 0.23; p < 0.0001). 50% and 56% of children were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). 55% and 47% of females were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). There is moderate statistical agreement of Hb concentration between HemoCue and DBS for both age groups. The choice of Hb assessment method has important implications for individual anemia diagnosis and population prevalence estimates. Further research is required to understand factors that influence the accuracy and reliability of DBS as a methodology for Hb assessment.
format Online
Article
Text
id pubmed-8085154
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80851542021-05-03 Agreement between dried blood spots and HemoCue in Tamil Nadu, India Roshania, Reshma P. Mehta, Rukshan V. Shete, Ashwini Bingewar, Rohini Kulkarni, Sangeeta Mahajan, Aprajit Miller, Grant Tarozzi, Alessandro Martorell, Reynaldo Sci Rep Article India retains the world’s largest burden of anemia despite decades of economic growth and anemia prevention programming. Accurate screening and estimates of anemia prevalence are critical for successful anemia control. Evidence is mixed on the performance of HemoCue, a point-of-care testing device most widely used for large-scale surveys. The use of dried blood spots (DBS) to assess hemoglobin (Hb) concentration is a potential alternative, particularly in field settings. The objective of this study is to assess Hb measurement agreement between capillary HemoCue and DBS among two age groups, children 6–59 months and females age 12–40 years. We analyzed data from the baseline round of a cluster randomized rice fortification intervention in Cuddalore district of Tamil Nadu, India. Capillary blood was collected from a subset of participants for Hb assessment by HemoCue 301 and DBS methods. We calculated Lin’s concordance correlation coefficient, and tested bias by conducting paired t-tests of Hb concentration. Independence of the bias and Hb magnitude was examined visually using Bland–Altman plots and statistically tested by Pearson’s correlation. We assessed differences in anemia classification using McNemar’s test of marginal homogeneity. Concordance between HemoCue and DBS Hb measures was moderate for both children 6–59 months (ρ(c) = 0.67; 95% CI 0.65, 0.71) and females 12–40 years (ρ(c) = 0.67: 95% CI 0.64, 0.69). HemoCue measures were on average 0.06 g/dL higher than DBS for children (95% CI 0.002, 0.12; p = 0.043) and 0.29 g/dL lower than DBS for females (95% CI − 0.34, − 0.23; p < 0.0001). 50% and 56% of children were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). 55% and 47% of females were classified as anemic according to HemoCue and DBS, respectively (p < 0.0001). There is moderate statistical agreement of Hb concentration between HemoCue and DBS for both age groups. The choice of Hb assessment method has important implications for individual anemia diagnosis and population prevalence estimates. Further research is required to understand factors that influence the accuracy and reliability of DBS as a methodology for Hb assessment. Nature Publishing Group UK 2021-04-29 /pmc/articles/PMC8085154/ /pubmed/33927229 http://dx.doi.org/10.1038/s41598-021-88425-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Roshania, Reshma P.
Mehta, Rukshan V.
Shete, Ashwini
Bingewar, Rohini
Kulkarni, Sangeeta
Mahajan, Aprajit
Miller, Grant
Tarozzi, Alessandro
Martorell, Reynaldo
Agreement between dried blood spots and HemoCue in Tamil Nadu, India
title Agreement between dried blood spots and HemoCue in Tamil Nadu, India
title_full Agreement between dried blood spots and HemoCue in Tamil Nadu, India
title_fullStr Agreement between dried blood spots and HemoCue in Tamil Nadu, India
title_full_unstemmed Agreement between dried blood spots and HemoCue in Tamil Nadu, India
title_short Agreement between dried blood spots and HemoCue in Tamil Nadu, India
title_sort agreement between dried blood spots and hemocue in tamil nadu, india
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085154/
https://www.ncbi.nlm.nih.gov/pubmed/33927229
http://dx.doi.org/10.1038/s41598-021-88425-y
work_keys_str_mv AT roshaniareshmap agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT mehtarukshanv agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT sheteashwini agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT bingewarrohini agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT kulkarnisangeeta agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT mahajanaprajit agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT millergrant agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT tarozzialessandro agreementbetweendriedbloodspotsandhemocueintamilnaduindia
AT martorellreynaldo agreementbetweendriedbloodspotsandhemocueintamilnaduindia